SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
Please provide your email address to receive an email when new articles are posted on . Psoriasis patients who self-administer bimekizumab experienced similar levels of comfort and success with both ...
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...
Industry growth is strongly linked to the increasing global burden of chronic diseases such as diabetes, autoimmune disorders, and cardiovascular conditions. As treatment protocols increasingly rely ...
(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities in the Prefilled Syringes Market include rapid growth driven by GLP-1 obesity therapeutics and rising self-injection demand, preference for ...
EXTON, Pa., Oct. 16, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST) (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced ...
The Food and Drug Administration’s (FDA) recent authorization of FluMist for at-home administration marks the beginning of a new chapter in vaccine access and delivery. Before now, self-administered ...
The MarketWatch News Department was not involved in the creation of this content. Prefilled Syringes Market to Surpass USD 18 Bn by 2031 as Biologics and Self-Injection Devices Drive Adoption, Says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results